What caused the ORPH.IR stock volume spike today?

The spike to **15,112** shares appears driven by large intraday trades and improved liquidity. There was no public earnings release. Monitor order book prints and any company notices for catalyst confirmation.

How does Meyka AI rate ORPH.IR stock?

Meyka AI rates ORPH.IR **67.24/100** (Grade B, HOLD). The grade factors in benchmark comparisons, sector performance, financials, and analyst signals. This is informational, not financial advice.

What price targets and risks apply to ORPH.IR stock?

Meyka AI's forecast model projects a base target of **EUR 0.19** (+35.71%) and a downside case **EUR 0.09** (-35.71%). Risks include low nominal price, episodic liquidity swings, and biotech trial or contract outcomes.

Should traders act on the intraday ORPH.IR stock spike?

Intraday traders can use the spike for short-term liquidity, but wait for follow-through above **EUR 0.16** or failure below **EUR 0.13**. Size positions conservatively given volatility.

EU Stocks

15,112 spike in ORPH.IR volume: Open Orphan Plc intraday 20 Feb 2026, watch

ByDanny Kontos February 20, 2026February 20, 2026

ORPH.IR stock opened steady at EUR 0.14 on 20 Feb 2026 while volume jumped to 15,112, versus an average volume of 192. The intraday volume spike is the main market signal today. Traders should note the large relative volume of 78.71x, short-term price averages and Healthcare sector trends. This piece explains what the spike means for liquidity, valuation, and next trading steps on EURONEXT.